Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
Departments of Pathology and Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Pathol Oncol Res. 2022 Feb 28;28:1610237. doi: 10.3389/pore.2022.1610237. eCollection 2022.
Undifferentiated round cell sarcomas (URCS) of soft tissue and bone and tumours of uncertain differentiation (TUD) are commonly ascribed to a subset of neoplasms with low frequency of NTRK gene fusions. However, more recently NTRK-rearranged round and spindle cell tumours have been noted in case reports and in limited or heterogeneous cohorts. The aim of our study was to investigate the presence of NTRK gene fusions in a large retrospective cohort of paediatric URCS and TUD after a systematic review of the diagnosis, according to the recently updated WHO classification scheme. One-hundred and five patients with diagnosis of URCS or TUD, involving the bone or soft tissue, were retrospectively evaluated. After the case selection and the histopathological review of the case cohort, pan-Trk immunohistochemistry (IHC) testing was performed on formalin-fixed paraffin-embedded (FFPE) tissues. Tumour RNA was extracted from FFPE tissue and subjected to next-generation sequencing (NGS) library preparation, using a 10-gene NGS fusion panel, sequenced on an Illumina MiSeq. The NGS-positive cases were further confirmed by real-time PCR. On immunohistochemical screening, 12/105 (11.4%) cases were positive using the pan-Trk antibody, showing three different staining patterns with the cytoplasmic distribution being most common. Molecular analysis using NGS and confirmed by the real-rime PCR detected two positive cases for the ETV6-NTRK3 fusion. The histological pattern of the two positive cases, together with the demonstration of the NTRK rearrangement, leaded to re-classify these previously not otherwise specified sarcomas with uncertain differentiation into the emerging category of NTRK-rearranged neoplasms. In addition, we found the two NTRK fused neoplasms showing a clinical indolent course, in contrast with literature.
未分化的圆形细胞肉瘤(URCS)和骨及软组织肿瘤的不定分化(TUD)通常归因于一组具有低频率 NTRK 基因融合的肿瘤。然而,最近在病例报告和有限或异质的队列中已经注意到 NTRK 重排的圆形和梭形细胞肿瘤。我们的研究目的是在对最近更新的世卫组织分类方案进行系统回顾后,在一个大型回顾性儿科 URCS 和 TUD 队列中调查 NTRK 基因融合的存在。对 105 例诊断为 URCS 或 TUD 的患者进行回顾性评估,这些患者涉及骨或软组织。在病例选择和病例队列的组织病理学复习后,对福尔马林固定石蜡包埋(FFPE)组织进行泛 Trk 免疫组织化学(IHC)检测。从 FFPE 组织中提取肿瘤 RNA,并使用 10 个基因 NGS 融合面板进行下一代测序(NGS)文库制备,在 Illumina MiSeq 上进行测序。对 NGS 阳性病例进一步通过实时 PCR 进行确认。在免疫组织化学筛选中,使用泛 Trk 抗体,12/105(11.4%)例呈阳性,具有三种不同的染色模式,最常见的是细胞质分布。使用 NGS 进行的分子分析并通过实时 PCR 进行确认,检测到 2 例 ETV6-NTRK3 融合阳性病例。这两个阳性病例的组织学模式,以及 NTRK 重排的证明,导致将这些以前未分类的具有不定分化的肉瘤重新归类为新兴的 NTRK 重排肿瘤类别。此外,我们发现这两个 NTRK 融合性肿瘤表现出临床惰性病程,与文献相反。